Equity Brief · Healthcare2026-05-20
RMD·Healthcare

ResMed Inc

I · Analiza AI

Pe scurt

ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).

ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].

ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.

Pe scurt AI analysisÎncredere 8/10

Scor Sentinellis

10/10

Financially healthy

Capitalizare bursieră

$30.1B

Venituri (12 luni)

$5.1B

II · Știri recente

Ce a mișcat prețul

3 stories · ranked by relevance

  • macro2026-05-20

    ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access

    Simply Wall St

  • macro2026-05-19

    Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

    Yahoo Finance

  • macro2026-05-19

    Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

    Yahoo Finance

Premium · gratuit cu orice cont

The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].

1 din 4 riscuri din acest raport

Riscuri

4

Oportunități

4

Semnale de alarmă

1

Conducere

10

Încă 18 constatări în raportul complet — gratuit cu orice cont.

Deblochează analiza completă ResMed Inc

Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.

  • 4 riscuri, 4 oportunități și 1 semnal de alarmă — fiecare cu sursa lui
  • Peste 100 de indicatori financiari, cu grafice și comparații
  • Rezumate complete ale știrilor, cu linkuri către surse
  • Echipa de conducere și remunerația
  • Export PDF pentru citit offline
Deblochează 9 constatări3 rapoarte gratuite · fără card

III · Companii similare

Ai putea citi și

Same sector · Healthcare or comparable health

Vrei compania asta pe lista ta?

Read three companies free. Fără card.

Primești 3 rapoarte gratuite